Literature DB >> 22535267

Age-related macular degeneration and long-term risk of stroke subtypes.

M Kamran Ikram1, Paul Mitchell, Ronald Klein, A Rickey Sharrett, David J Couper, Tien Y Wong.   

Abstract

BACKGROUND AND
PURPOSE: We examined the relationship of age-related macular degeneration (AMD) with incident stroke, including stroke subtypes of cerebral infarction and intracerebral hemorrhage.
METHODS: We included 12 216 participants with retinal photographs taken at the third examination visit (1993-1995) from the Atherosclerosis Risk in Communities (ARIC) Study, a population-based cohort study in middle-aged persons. Images were evaluated for AMD signs according to a standardized protocol. Incident events of stroke and its subtypes were identified and validated through case record review over time.
RESULTS: AMD was diagnosed in 591 participants, of whom 576 had early and 15 late AMD. After a mean follow-up of 13.0 years (SD, 3.3), 619 persons developed an incident stroke, including 548 cerebral infarction and 57 intracerebral hemorrhages. Participants with any AMD were at an increased risk of stroke (multivariable adjusted hazard ratio, 1.51; 95% CI, 1.11-2.06) with a stronger association for intracerebral hemorrhage (hazard ratio, 2.64; 95% CI, 1.18-5.87) than cerebral infarction (hazard ratio, 1.42; 95% CI, 1.01-1.99).
CONCLUSIONS: Persons with AMD are at an increased risk of both cerebral infarction and intracerebral hemorrhage. These data provide further insight into common pathophysiological processes between AMD and stroke subtypes.

Entities:  

Mesh:

Year:  2012        PMID: 22535267      PMCID: PMC3361598          DOI: 10.1161/STROKEAHA.112.654632

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  9 in total

Review 1.  Retinal signs and stroke: revisiting the link between the eye and brain.

Authors:  Michelle L Baker; Peter J Hand; Jie Jin Wang; Tien Y Wong
Journal:  Stroke       Date:  2008-02-28       Impact factor: 7.914

2.  Age-related macular degeneration: why should stroke physicians care?

Authors:  Tien Y Wong
Journal:  Stroke       Date:  2010-02-11       Impact factor: 7.914

3.  Emerging evidence concerning systemic safety of anti-VEGF agents--should ophthalmologists be concerned?

Authors:  Laurence S Lim; Chui Ming Gemmy Cheung; Paul Mitchell; Tien Y Wong
Journal:  Am J Ophthalmol       Date:  2011-09       Impact factor: 5.258

4.  Age-related macular degeneration and the risk of stroke: the Rotterdam study.

Authors:  Renske G Wieberdink; Lintje Ho; M Kamran Ikram; Peter J Koudstaal; Albert Hofman; Paulus T V M de Jong; Johannes R Vingerling; Monique M B Breteler
Journal:  Stroke       Date:  2011-06-16       Impact factor: 7.914

5.  Neovascular age-related macular degeneration and the risk of stroke: a 5-year population-based follow-up study.

Authors:  Chao-Chien Hu; Jau-Der Ho; Herng-Ching Lin
Journal:  Stroke       Date:  2010-02-11       Impact factor: 7.914

6.  Age-related macular degeneration and risk for stroke.

Authors:  Tien Yin Wong; Ronald Klein; Cong Sun; Paul Mitchell; David J Couper; Hong Lai; Larry D Hubbard; A Richey Sharrett
Journal:  Ann Intern Med       Date:  2006-07-18       Impact factor: 25.391

7.  Age-related macular degeneration and risk of coronary heart disease and stroke: the Cardiovascular Health Study.

Authors:  Cong Sun; Ronald Klein; Tien Y Wong
Journal:  Ophthalmology       Date:  2009-07-09       Impact factor: 12.079

8.  Early age-related maculopathy in the cardiovascular health study.

Authors:  Ronald Klein; Barbara E K Klein; Emily K Marino; Lewis H Kuller; Curt Furberg; Gregory L Burke; Larry D Hubbard
Journal:  Ophthalmology       Date:  2003-01       Impact factor: 12.079

9.  Age-related macular degeneration and mortality from cardiovascular disease or stroke.

Authors:  J S L Tan; J J Wang; G Liew; E Rochtchina; P Mitchell
Journal:  Br J Ophthalmol       Date:  2008-02-29       Impact factor: 4.638

  9 in total
  17 in total

1.  Mortality associated with bevacizumab intravitreal injections in age-related macular degeneration patients after acute myocardial infarct: a retrospective population-based survival analysis.

Authors:  Joel Hanhart; Doron S Comaneshter; Yossi Freier-Dror; Shlomo Vinker
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-02-10       Impact factor: 3.117

2.  Introducing Anti-Vascular Endothelial Growth Factor Therapies for AMD Did Not Raise Risk of Myocardial Infarction, Stroke, and Death.

Authors:  Arseniy P Yashkin; Paul Hahn; Frank A Sloan
Journal:  Ophthalmology       Date:  2016-08-11       Impact factor: 12.079

Review 3.  Intravitreal Bevacizumab and Cardiovascular Risk in Patients with Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Randomized Controlled Trials and Observational Studies.

Authors:  Ivana Mikačić; Damir Bosnar
Journal:  Drug Saf       Date:  2016-06       Impact factor: 5.606

4.  Evaluation of plasma vascular endothelial growth factor levels after intravitreal injection of ranibizumab and aflibercept for exudative age-related macular degeneration.

Authors:  Izumi Yoshida; Tomoaki Shiba; Hikari Taniguchi; Mao Takahashi; Takeyoshi Murano; Nobuyuki Hiruta; Yuichi Hori; Hdieaki Bujo; Takatoshi Maeno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-17       Impact factor: 3.117

Review 5.  Age-Related Macular Degeneration and Incident Stroke: A Systematic Review and Meta-Analysis.

Authors:  Antonio B Fernandez; Gregory A Panza; Benjamin Cramer; Saurav Chatterjee; Ramya Jayaraman; Wen-Chih Wu
Journal:  PLoS One       Date:  2015-11-18       Impact factor: 3.240

6.  Age-related macular degeneration and the incidence of cardiovascular disease: a systematic review and meta-analysis.

Authors:  Juan Wu; Miki Uchino; Srinivas M Sastry; Debra A Schaumberg
Journal:  PLoS One       Date:  2014-03-28       Impact factor: 3.240

7.  Ranibizumab and risk of hospitalisation for ischaemic stroke and myocardial infarction in patients with age-related macular degeneration: a self-controlled case-series analysis.

Authors:  Nicole L Pratt; Emmae N Ramsay; Anna Kemp; Lisa M Kalisch-Ellett; Sepehr Shakib; Gillian E Caughey; Philip Ryan; Stephen Graves; Elizabeth E Roughead
Journal:  Drug Saf       Date:  2014-12       Impact factor: 5.606

Review 8.  Relation between Age-Related Macular Degeneration and Cardiovascular Events and Mortality: A Systematic Review and Meta-Analysis.

Authors:  Jie Wang; Yangjing Xue; Saroj Thapa; Luping Wang; Jifei Tang; Kangting Ji
Journal:  Biomed Res Int       Date:  2016-12-14       Impact factor: 3.411

Review 9.  Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors.

Authors:  Katie L Pennington; Margaret M DeAngelis
Journal:  Eye Vis (Lond)       Date:  2016-12-22

10.  Sensory Impairments and Cardiovascular Disease Incidence and Mortality in Older British Community-Dwelling Men: A 10-Year Follow-Up Study.

Authors:  Ann E M Liljas; S Goya Wannamethee; Peter H Whincup; Olia Papacosta; Kate Walters; Steve Iliffe; Lucy T Lennon; Livia A Carvalho; Sheena E Ramsay
Journal:  J Am Geriatr Soc       Date:  2016-02       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.